2024-02-292025-04-302025-04-30false14650201CMSMEE MEDICAL LTD2025-06-11falseiso4217:GBPxbrli:pure146502012024-02-29146502012025-04-30146502012024-02-292025-04-30146502012023-02-08146502012024-02-28146502012023-02-082024-02-2814650201bus:SmallEntities2024-02-292025-04-3014650201bus:AuditExempt-NoAccountantsReport2024-02-292025-04-3014650201bus:FullAccounts2024-02-292025-04-3014650201bus:PrivateLimitedCompanyLtd2024-02-292025-04-3014650201core:WithinOneYear2025-04-3014650201core:AfterOneYear2025-04-3014650201core:WithinOneYear2024-02-2814650201core:AfterOneYear2024-02-2814650201core:ShareCapital2025-04-3014650201core:SharePremium2025-04-3014650201core:RevaluationReserve2025-04-3014650201core:OtherReservesSubtotal2025-04-3014650201core:RetainedEarningsAccumulatedLosses2025-04-3014650201core:ShareCapital2024-02-2814650201core:SharePremium2024-02-2814650201core:RevaluationReserve2024-02-2814650201core:OtherReservesSubtotal2024-02-2814650201core:RetainedEarningsAccumulatedLosses2024-02-2814650201core:LandBuildings2025-04-3014650201core:PlantMachinery2025-04-3014650201core:Vehicles2025-04-3014650201core:FurnitureFittings2025-04-3014650201core:OfficeEquipment2025-04-3014650201core:NetGoodwill2025-04-3014650201core:IntangibleAssetsOtherThanGoodwill2025-04-3014650201core:ListedExchangeTraded2025-04-3014650201core:UnlistedNon-exchangeTraded2025-04-3014650201core:LandBuildings2024-02-2814650201core:PlantMachinery2024-02-2814650201core:Vehicles2024-02-2814650201core:FurnitureFittings2024-02-2814650201core:OfficeEquipment2024-02-2814650201core:NetGoodwill2024-02-2814650201core:IntangibleAssetsOtherThanGoodwill2024-02-2814650201core:ListedExchangeTraded2024-02-2814650201core:UnlistedNon-exchangeTraded2024-02-2814650201core:LandBuildings2024-02-292025-04-3014650201core:PlantMachinery2024-02-292025-04-3014650201core:Vehicles2024-02-292025-04-3014650201core:FurnitureFittings2024-02-292025-04-3014650201core:OfficeEquipment2024-02-292025-04-3014650201core:NetGoodwill2024-02-292025-04-3014650201core:IntangibleAssetsOtherThanGoodwill2024-02-292025-04-3014650201core:ListedExchangeTraded2024-02-292025-04-3014650201core:UnlistedNon-exchangeTraded2024-02-292025-04-3014650201core:MoreThanFiveYears2024-02-292025-04-3014650201core:Non-currentFinancialInstruments2025-04-3014650201core:Non-currentFinancialInstruments2024-02-2814650201dpl:CostSales2024-02-292025-04-3014650201dpl:DistributionCosts2024-02-292025-04-3014650201core:LandBuildings2024-02-292025-04-3014650201core:PlantMachinery2024-02-292025-04-3014650201core:Vehicles2024-02-292025-04-3014650201core:FurnitureFittings2024-02-292025-04-3014650201core:OfficeEquipment2024-02-292025-04-3014650201dpl:AdministrativeExpenses2024-02-292025-04-3014650201core:NetGoodwill2024-02-292025-04-3014650201core:IntangibleAssetsOtherThanGoodwill2024-02-292025-04-3014650201dpl:GroupUndertakings2024-02-292025-04-3014650201dpl:ParticipatingInterests2024-02-292025-04-3014650201dpl:GroupUndertakingscore:ListedExchangeTraded2024-02-292025-04-3014650201core:ListedExchangeTraded2024-02-292025-04-3014650201dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-02-292025-04-3014650201core:UnlistedNon-exchangeTraded2024-02-292025-04-3014650201dpl:CostSales2023-02-082024-02-2814650201dpl:DistributionCosts2023-02-082024-02-2814650201core:LandBuildings2023-02-082024-02-2814650201core:PlantMachinery2023-02-082024-02-2814650201core:Vehicles2023-02-082024-02-2814650201core:FurnitureFittings2023-02-082024-02-2814650201core:OfficeEquipment2023-02-082024-02-2814650201dpl:AdministrativeExpenses2023-02-082024-02-2814650201core:NetGoodwill2023-02-082024-02-2814650201core:IntangibleAssetsOtherThanGoodwill2023-02-082024-02-2814650201dpl:GroupUndertakings2023-02-082024-02-2814650201dpl:ParticipatingInterests2023-02-082024-02-2814650201dpl:GroupUndertakingscore:ListedExchangeTraded2023-02-082024-02-2814650201core:ListedExchangeTraded2023-02-082024-02-2814650201dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-02-082024-02-2814650201core:UnlistedNon-exchangeTraded2023-02-082024-02-2814650201core:NetGoodwill2025-04-3014650201core:IntangibleAssetsOtherThanGoodwill2025-04-3014650201core:LandBuildings2025-04-3014650201core:PlantMachinery2025-04-3014650201core:Vehicles2025-04-3014650201core:FurnitureFittings2025-04-3014650201core:OfficeEquipment2025-04-3014650201core:AfterOneYear2025-04-3014650201core:WithinOneYear2025-04-3014650201core:ListedExchangeTraded2025-04-3014650201core:UnlistedNon-exchangeTraded2025-04-3014650201core:ShareCapital2025-04-3014650201core:SharePremium2025-04-3014650201core:RevaluationReserve2025-04-3014650201core:OtherReservesSubtotal2025-04-3014650201core:RetainedEarningsAccumulatedLosses2025-04-3014650201core:NetGoodwill2024-02-2814650201core:IntangibleAssetsOtherThanGoodwill2024-02-2814650201core:LandBuildings2024-02-2814650201core:PlantMachinery2024-02-2814650201core:Vehicles2024-02-2814650201core:FurnitureFittings2024-02-2814650201core:OfficeEquipment2024-02-2814650201core:AfterOneYear2024-02-2814650201core:WithinOneYear2024-02-2814650201core:ListedExchangeTraded2024-02-2814650201core:UnlistedNon-exchangeTraded2024-02-2814650201core:ShareCapital2024-02-2814650201core:SharePremium2024-02-2814650201core:RevaluationReserve2024-02-2814650201core:OtherReservesSubtotal2024-02-2814650201core:RetainedEarningsAccumulatedLosses2024-02-2814650201core:NetGoodwill2023-02-0814650201core:IntangibleAssetsOtherThanGoodwill2023-02-0814650201core:LandBuildings2023-02-0814650201core:PlantMachinery2023-02-0814650201core:Vehicles2023-02-0814650201core:FurnitureFittings2023-02-0814650201core:OfficeEquipment2023-02-0814650201core:AfterOneYear2023-02-0814650201core:WithinOneYear2023-02-0814650201core:ListedExchangeTraded2023-02-0814650201core:UnlistedNon-exchangeTraded2023-02-0814650201core:ShareCapital2023-02-0814650201core:SharePremium2023-02-0814650201core:RevaluationReserve2023-02-0814650201core:OtherReservesSubtotal2023-02-0814650201core:RetainedEarningsAccumulatedLosses2023-02-0814650201core:AfterOneYear2024-02-292025-04-3014650201core:WithinOneYear2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:CostValuation2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-292025-04-3014650201core:Non-currentFinancialInstrumentscore:CostValuation2025-04-3014650201core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-04-3014650201core:Non-currentFinancialInstrumentscore:CostValuation2024-02-2814650201core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-02-2814650201core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-02-2814650201core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-02-2814650201core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-02-2814650201core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-02-2814650201core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-02-2814650201core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-02-2814650201core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-02-2814650201bus:Director12024-02-292025-04-30

CMSMEE MEDICAL LTD

Registered Number
14650201
(England and Wales)

Unaudited Financial Statements for the Period ended
30 April 2025

CMSMEE MEDICAL LTD
Company Information
for the period from 29 February 2024 to 30 April 2025

Director

Christopher Michael Mee

Registered Address

77 Woodbank Road
Groby
Leicester
LE6 0BP

Registered Number

14650201 (England and Wales)
CMSMEE MEDICAL LTD
Balance Sheet as at
30 April 2025

Notes

30 Apr 2025

28 Feb 2024

£

£

£

£

Fixed assets
Intangible assets3-9,600
-9,600
Current assets
Cash at bank and on hand-7,232
-7,232
Creditors amounts falling due within one year5-(12,318)
Net current assets (liabilities)-(5,086)
Total assets less current liabilities-4,514
Net assets-4,514
Capital and reserves
Called up share capital11
Profit and loss account(1)4,513
Shareholders' funds-4,514
The financial statements were approved and authorised for issue by the Director on 11 June 2025, and are signed on its behalf by:
Christopher Michael Mee
Director
Registered Company No. 14650201
CMSMEE MEDICAL LTD
Notes to the Financial Statements
for the period ended 30 April 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
2.Average number of employees

20252024
Average number of employees during the year11
3.Intangible assets

Other

Total

££
Cost or valuation
At 29 February 2412,00012,000
Disposals(12,000)(12,000)
Amortisation and impairment
At 29 February 242,4002,400
Charge for year2,8002,800
On disposals(5,200)(5,200)
Net book value
At 30 April 25--
At 28 February 249,6009,600
4.Debtors: amounts due within one year
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security-2,325
Other creditors-9,211
Accrued liabilities and deferred income-782
Total-12,318
6.Change in reporting period and impact on comparability
The company was incorporated on 8 February 2023 and therefore the current figures represent the period from this date to 28 February 2024.